Jaisim Shah

  • Mr. Shah has served as a director since 2013
  • 25+ years of experience in the pharmaceutical industry
  • Mr. Shah currently serves as the CEO and President of Scilex Holding and Scilex Pharmaceutical
  • Prior to Scilex, he served as CEO and President of Semnur Pharmaceuticals (acquired by Scilex Pharmaceuticals) since its inception in 2013
  • From 2011 to 2012, he served as Chief Business Officer of Elevation Pharmaceuticals where he focused on financing, mergers and acquisitions, and business development
  • Prior to Elevation, Mr. Shah was President of Zelos Therapeutics, where he focused on financing and business development
  • Prior to Zelos, Mr. Shah was the Senior Vice President and Chief Business Officer at CytRx.  Previously, Mr. Shah was Chief Business Officer at Facet Biotech and PDL BioPharma where he completed numerous licensing/ partnering and strategic transactions
  • Prior to PDL, Mr. Shah was VP of Global Marketing at BMS where he received the “Presidents Award” for completing one of the most significant collaborations in the company’s history  
  • M.A. and M.B.A.